Treatment of Glomerular Diseases in Lebanon
- 1 January 2021
- journal article
- research article
- Published by Medknow in Saudi Journal of Kidney Diseases and Transplantation
- Vol. 32 (4), 1089-1100
- https://doi.org/10.4103/1319-2442.338282
Abstract
Glomerulonephritis (GN) is rare kidney disease that often requires treatment with immunosuppressive drugs. The choice of therapy usually relies on international guidelines. There are no data so far regarding the treatment of glomerular diseases in the eastern Mediterranean region. This study aimed to describe the most frequently treated glomerular diseases among the Lebanese population. This is a retrospective study that reviewed all patients’ medication coverage claims, presented at the Lebanese Ministry of Public Health between 2014 and 2015. All patients that had kidney biopsies in their charts were included. A total of 144 patients were included: 35 children and 109 adults. Half of the children had minimal change disease treated with mycophenolate mofetil (MMF). In adults, 33% had lupus nephritis (LN) with a male to female ratio 12/24, 28.4% focal segmental glomerulosclerosis (FSGS), 14.6% membranous nephropathy (MN), and 24% other types. There was a significant difference in age among different GN (P = 0.01). MMF was the most commonly used drug in adults: 88.8% of LN cases, 51.6% in FSGS, 18.7% in MN, and 100% in immunoglobulin A nephropathy. This study showed that LN is the most frequently treated GN in Lebanon and was managed according to guidelines. MMF use was prevailing even in cases not suggested by the Kidney Disease Improving Global Outcomes. Further studies are needed to see whether these results apply to other countries.Keywords
This publication has 20 references indexed in Scilit:
- The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patientKidney International, 2012
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnnals Of The Rheumatic Diseases, 2012
- Idiopathic Membranous Nephropathy: Clinical and Histologic Prognostic Features and Treatment Patterns over Time at a Tertiary Referral CenterAmerican Journal of Nephrology, 2012
- Eculizumab for Dense Deposit Disease and C3 GlomerulonephritisClinical Journal of the American Society of Nephrology, 2012
- Clinical trial of focal segmental glomerulosclerosis in children and young adultsKidney International, 2011
- A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinityNephrology Dialysis Transplantation, 2010
- Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2010
- Long-term study of mycophenolate mofetil treatment in IgA nephropathyKidney International, 2010
- The Natural History of the Non-Nephrotic Membranous Nephropathy PatientClinical Journal of the American Society of Nephrology, 2009
- Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi ArabiaRheumatology International, 2009